Magnetic resonance imaging findings of hepatocellular carcinoma: typical and atypical findings

Open access

Abstract

Background: Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. Magnetic resonance imaging has been widely used for detection and characterization of HCC. Objective: Describe MRI findings of HCC and to define the typical and atypical appearances of HCC on magnetic resonance images. Methods: We retrospectively reviewed MRI findings of 100 HCC in 78 patients. Diagnosis was confirmed by angiography, pathology or follow up imaging. The signal intensity, size, margins, enhancement pattern, and other features were evaluated. Imaging findings between small HCC (< 2 cm) and large HCC (>2 cm) were compared. Results: The most common signal intensity of HCC on unenhanced T1- and T2-weighted images was hypointense on T1-weighted images and hyperintense on T2-weighted images (65%). Most HCC (91%) were hyperintense on T2-weighted images. Isointensity on T2-weighted images were found in 9% of HCC. The typical enhancement pattern of HCC was enhancement on the arterial phase and washout on the portovenous phase (84%). Atypical enhancement pattern of HCC were enhancement on the portovenous phase in 5%, rim enhancement on the arterial phase or portovenous phase were demonstrated in 2%. Hyperintensity of the tumor on delayed phase was found in 19%. There was no statistically significant difference in signal intensity, enhancement, and washout pattern between small and large HCC. Fatty metamorphosis, mosaic pattern, necrosis, capsule and vascular involvement were found in 18%, 42%, 5%, 62%, and 6%, respectively. Mosaic pattern, necrosis, capsule, and vascular involvement were observed more frequently in large HCC. Conclusion: The typical appearance of HCC was hypointense on T1-weighted, hyperintense on T2-weighted images, arterial enhancement and portovenous washout. Atypical appearances of HCC were rim enhancement on the arterial phase or portovenous phase and persistent enhancement on the delayed phase

1. Ros PR, Erturk SM. Malignant tumors of the liver. In: Gore RM, Levine MS. Gastrointestinal radiology, 3rd ed. Philadelphia:Saunders Elsevier; 2008. p. 1624-33.

2. Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics. 2008; 28:747-69.

3. Hussain SM, Semelka RC, Mitchell DG. MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am. 2002; 10:31-52.

4. Yamashita Y, Mitsuzaki K, Yi T, Ogata I, Nishiharu T, Urata J, et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology. 1996; 200:79-84.

5. Colli A, Fraquelli M, Casazza G, Massironi S, Colucci A, Conte D, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol. 2006; 101:513-23.

6. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005; 42:1208-36.

7. Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: Correlation of MR imaging and histopathologic findings. Radiology. 1992; 183: 819-25.

8. Stevens WR, Johnson CD, Stephens DH, Batts KP. CT findings in hepatocellular carcinoma: correlation of tumor characteristics with causative factors, tumor size, and histologic tumor grade. Radiology. 1994; 191: 531-7.

9. Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology. 2008; 247:311-30.

10. Kelekis NL, Semelka RC, Worawattanakul S, Lange EE, Ascher SM, Ahn IO, et al. Hepatocellular carcinoma in North America: A multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial Gadolinium-enhanced gradient-echo images. Am J Roentgenol. 1998; 170:1005-13.

11. Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D. Hepatocellular carcinoma in cirrhosis: Enhancement patterns at dynamic Gadolinium- and Superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology. 2005; 237:520-8.

12. Matsui O. Imaging of multistep human hepatocarcinogenesis by CT during intra-arterial contrast injection. Intervirology. 2004; 47:3-5.

13. Gabata T, Matsui O, Kadoya M, Yoshikawa J, Ueda K, Kawamori Y, et al. Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging. 1998; 23: 309-13.

14. Mahfouz AE, Hamm B, Wolf KJ. Dynamic gadopentetate dimeglumine-enhanced MR imaging of hepatocellular carcinoma. Eur J Radiol. 1993; 3:453-8.

15. Freeny PC, Baron RL, Teefey SA. Hepatocellular carcinoma: reduced frequency of typical findings with dynamic contrast-enhanced CT in a non-Asian population. Radiology. 1992; 182:143-8.

16. Karahan OI, Yikilmaz A, Artis T, Canoz O, Coskun A, Torun E. Contrast-enhanced dynamic magnetic resonance imaging findings of hepatocellular carcinoma and their correlation with histopathologic findings. Eur J Radiol. 2006; 57:445-52.

17. Singcharoen T, Udompanich O, Chakkapak K. Hepatocellular carcinoma: MR imaging. Australas Radiol. 1992; 36:34-6.

18. Ito K. Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging. Eur J Radiol. 2006; 58:186-99.

19. Choi BI, Lee GK, Kim ST, Han MC. Mosaic pattern of encapsulated hepatocellular carcinoma: Correlation of magnetic resonance imaging and pathology. Gastrointest Radiol. 1990; 15:238-40.

20. Jonas S, Bechstein WO, Steinmuller T, Herrmann M, Radke C, Berg T et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 2001; 33:1080-6.

21. Vajragupta L, Tumkosit M, Brown PL, Wangsuphachart S. Detection of small primary and secondary malignant hepatic tumors with superparamagnetic iron oxideenhanced magnetic resonance imaging. Asian Biomed. 2008; 2:135-9.

Journal Information


IMPACT FACTOR 2017: 0.209
5-year IMPACT FACTOR: 0.243

CiteScore 2017: 0.24

SCImago Journal Rank (SJR) 2017: 0.162
Source Normalized Impact per Paper (SNIP) 2017: 0.173

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 102 76 8
PDF Downloads 51 41 4